Wealthcare Capital Management LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 42.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 852 shares of the healthcare conglomerate’s stock after acquiring an additional 252 shares during the quarter. Wealthcare Capital Management LLC’s holdings in UnitedHealth Group were worth $ 434,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Palisades Hudson Asset Management LP boosted its stake in UnitedHealth Group by 2.0% during the fourth quarter. Palisades Hudson Asset Management LP now owns 1,078 shares of the healthcare conglomerate’s stock worth $ 542,000 after buying an additional 21 shares during the last quarter. Charter Oak Capital Management LLC boosted its stake in UnitedHealth Group by 2.4% during the fourth quarter. Charter Oak Capital Management LLC now owns 881 shares of the healthcare conglomerate’s stock worth $ 442,000 after buying an additional 21 shares during the last quarter. Oxford Financial Group Ltd. boosted its stake in UnitedHealth Group by 3.0% during the fourth quarter. Oxford Financial Group Ltd. now owns 720 shares of the healthcare conglomerate’s stock worth $ 362,000 after buying an additional 21 shares during the last quarter. Griffin Asset Management Inc. boosted its stake in UnitedHealth Group by 0.3% during the first quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock worth $ 3,414,000 after buying an additional 21 shares during the last quarter. Finally, Donald L. Hagan LLC lifted its stake in shares of UnitedHealth Group by 1.2% in the 4th quarter. Donald L. Hagan LLC now owns 1,854 shares of the healthcare conglomerate’s stock valued at $ 931,000 after purchasing an additional 22 shares during the last quarter. 87.48% of the stock is owned by hedge funds and other institutional investors.
In other UnitedHealth Group news, Director Frederick William Mcnabb III acquired 89 shares of the business’s stock in a transaction on Thursday, May 26th. The stock was purchased at an average price of $ 504.32 per share, for a total transaction of $ 44,884.48. Following the completion of the transaction, the director now owns 11,259 shares of the company stock, valued at approximately $ 5,678,138.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction on Thursday, May 19th. The stock was sold at an average price of $ 478.96, for a total value of $ 1,197,400.00. Following the completion of the transaction, the director now owns 1,215,000 shares of the company stock, valued at approximately $ 581,936,400. The disclosure for this sale can be found here. 0.40% of the stock is owned by company insiders.
Several research analysts have weighed in on UNH shares. StockNews.com started coverage on shares of UnitedHealth Group in a research note on Thursday, March 31st. They set a “strong-buy” rating for the company. BMO Capital Markets increased their target price on shares of UnitedHealth Group from $ 510.00 to $ 600.00 and gave the stock a “market perform” rating in a research note on Tuesday, April 19th. Raymond James raised their price objective on shares of UnitedHealth Group from $ 540.00 to $ 620.00 and gave the company a “strong-buy” rating in a research note on Tuesday, April 19th. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $ 613.00 to $ 612.00 and set an “overweight” rating for the company in a research note on Wednesday, May 25th. Finally, Cowen raised their price objective on shares of UnitedHealth Group from $ 512.00 to $ 596.00 in a research note on Monday, April 18th. Three equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $ 555.73.
UNH stock opened at $ 489.68 on Thursday. The company has a market capitalization of $ 459.40 billion, a P / E ratio of 26.80, a PEG ratio of 1.41 and a beta of 0.83. UnitedHealth Group Incorporated has a twelve month low of $ 383.12 and a twelve month high of $ 553.29. The business has a 50 day simple moving average of $ 496.56 and a 200-day simple moving average of $ 490.86. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.54.
UnitedHealth Group (NYSE: UNH – Get Rating) last issued its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 earnings per share for the quarter, topping the estimate consensus of $ 5.40 by $ 0.09. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The firm had revenue of $ 80.15 billion during the quarter, compared to the consensus estimate of $ 78.77 billion. During the same period last year, the company earned $ 5.31 earnings per share. The company revenue for the quarter was up 14.2% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 21.75 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be issued a dividend of $ 1.65 per share. The ex-dividend date is Thursday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $ 1.45. This represents a $ 6.60 annualized dividend and a dividend yield of 1.35%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 36.12%.
About UnitedHealth Group: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
See Also:
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE: UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.
.